Conclusion
One of the recurring themes in the fight against HIV and other STDs is the recognition that although many of the tools needed to control the spread of disease do exist, they are not widely used or available. The female condom is one such tool, and an effective microbicide will also add to the number of options at a woman’s disposal. Ensuring that these tools are available to women and couples should be policy and program planning priorities. For women who are vulnerable and are unable to negotiate the use of male condoms or to refuse sex, the female condom and microbicides are vital options. To meet the needs of these women, we must ensure the allocation of adequate resources for microbicide development and trials, the procurement of female condoms, and the provision of the necessary support for women and men who choose to use these options.
Horizons is an HIV/AIDS operations research program supported by the United States Agency for International Development.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Akbar J, Phillips J, Koenig M. Trends in contraceptive method mix, continuation rates and failure rates in Matlab, Bangladesh: 1978–87. In: Measuring the dynamics of contraceptive use. New York: United Nations, 1990.
Pariani S, Heer D, Van Arsdol M, Continued contraceptive use in five family planning clinics in Surabaya, Indonesia. Studies in Family Planning, 1987;22:384–390.
Latka M, Gollub E, French P, et al. Male-condom and female-condom use among women after counseling in a risk-reduction hierarchy for STD prevention. Sex Transm Dis, 2000;27:431–437.
Ray S, Bassett M, Maposhere C, et al. Acceptability of the female condom in Zimbabwe: Positive but male-centered responses. Reproductive. Health Matters, 1995;5:68–79.
Kerrigan D, Mobley S, Rutenberg N, et al. The Female Condom: Dynamics of Use in Urban Zimbabwe. New York: Population Council/Horizons Report, 2000.
Bentley ME, Morrow KM, Fullem A, et al. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann. Perspect, 2000;32:184–188.
Elias CJ, Coggins C, Alvarez F, et al. Colposcopic evaluation of a vaginal gel formulation of iotacarrageenan. Contraception, 1997;57:387–389.
Coggins C, Blanchard K, Alvarez F, et al. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Trans Inf, 2000;76:480–483.
Coggins C, Blanchard K, Friedland B. Men’s attitudes toward a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reproductive. Health Matters, 2000;8:132–141.
World Health Organization. The Female Condom:. A review. Geneva, Switzerland: WHO, 1997.
Cecil H, Perry M, Seal D, et al. The female condom: What we have learned thus far? AIDS and Behavior, 1998;2:241–256.
Rees H, Beksinska M, Mqoqi N, et al. Multiphased study to investigate the safety of re-use of the female condom. Johannesburg, South Africa: Reproductive Health Research Unit, Department of Obstetrics and Gynaecology, Baragwanath Hospital, February, 1999.
Neilsen G. Background Paper: Programmatic Issues. WHO/UNAIDS Consultation on the Safety and Feasibility of the Re-use of the Female Condom. Geneva: WHO/UNAIDS, June, 2000.
Rees H, Beksinska M, Dickson-Tetteh KE, et al. The re-use of the female condom in a multi-phased study. Technical Report to WHO Consultation. Unpublished paper. Geneva, Switzerland: World Health Organization, 2000.
Smith JB, Nkhama G, Sebastian P, et al. Qualitative research on condom research among women in two developing countries. North Carolina: Family Health International, 1999.
Joannis C, Latka M, Glover LH, et al. Structural Integrity of the Female Condom after a Single Use, Washing, Disinfection. Family Health. International, Draft, 2000.
Information Update: Consultation on Re-use of the Female Condom. Geneva, Switzerland: WHO and UNAIDS, 2000.
Alliance for Microbicide Development. Microbicides in development—complete listing. Alliance for Microbicide Development Web site. Available at: http://www.microbicide.org/products%20in%20dev.htm. Accessed January 24, 2002.
van Damme L, Rosenberg ZF. Microbicides and barrier methods in HIV prevention. AIDS, 1999; 13(suppl A):S85–S92.
Kreiss J, Ngugi E, Holmes KK, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA, 1992;268:477–482.
Roddy RE, Zekeng L, Ryan KA, et al. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med, 1998;339:504–510.
van Damme L. Advances in topical microbicides. Plenary presentation at the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa. Abstract PL04.
Zaretsky FR, Pearce-Pratt R, Phillips DM. Sulfated polyanions block Chlamydia trachomatis infection of cervix derived human epithelia. Infect Immunol, 1995;63:3520–3526.
Pearce-Pratt R, Phillips DM. Sulphated polysaccharides inhibit lymphocyte-to-epithelial transmission of HIV. Biol Reprod, 1996;54:173–182.
Zacharopoulos V, Phillips DM. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin Diag Lab Immunol, 1997;4:465–468.
Bourne N, Bernstein DI, Ireland J, et al. The topical microbicide PRO2000 protects against genital herpes in a mouse model. J Infect Dis, 1999;180:203–205.
Phillips DM, Zacharopoulos V. Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. Contraception, 1998;57:341–348.
Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet, 1997;350:546–550.
Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: associated with increased acquisition of HIV AIDS, 1998;12:1699–1706.
Wainberg M. Future microbicides research should focus on specific anti-HIV approaches. Presentation at the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa.
Ramjee, G, Morar NS, Alary M, et al. Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world. AIDS, 2000; 14:2553–2557.
Friedland B. Informed consent in microbicides testing. Presentation at Microbicides 2000; March 13–16, 2000; Washington, DC.
Potts M. Thinking about vaginal microbicide testing. Am J Public Health, 2000;90:188–190.
van de Wijgert J, Elias C, Ellertson C, et al. Condom promotion in microbicide trials. Am J. Public Health, 2000;90:1153–1154.
de Zoysa I, Elias CJ, Bentley ME. Microbicide research and “the investigator’s dilemma” Am J. Public Health, 2000;90:1155.
Heise L, McGrory E, Wood S. Practical and ethical dilemmas in the clinical testing of microbicides: A report on a symposium. International Women’s Health Coalition, New York, 1998.
Fonn S, McGrory E. Informing research on HIV prevention: A consultation. New York: Population Council, 1999.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Esu-Williams, E., Blanchard, K. (2002). Female Condoms and Microbicides. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_32
Download citation
DOI: https://doi.org/10.1007/0-306-47817-X_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46699-1
Online ISBN: 978-0-306-47817-8
eBook Packages: Springer Book Archive